Association between SARS-CoV-2 RNAemia, skewed T cell responses, inflammation, and severity in hospitalized COVID-19 people living with HIV
© 2023 The Authors..
Severe COVID-19 outcomes have been reported in people living with HIV (PLWH), yet the underlying pathogenetic factors are largely unknown. We therefore aimed to assess SARS-CoV-2 RNAemia and plasma cytokines in PLWH hospitalized for COVID-19 pneumonia, exploring associations with magnitude and functionality of SARS-CoV-2-specific immune responses. Eighteen unvaccinated PLWH (16/18 on cART; median CD4 T cell count 361.5/μL; HIV-RNA<50 cp/mL in 15/18) and 18 age/sex-matched people without HIV were consecutively recruited at a median time of 10 days from symptoms onset. PLWH showed greater SARS-CoV-2 RNAemia, a distinct plasma cytokine profile, and worse respiratory function (lower PaO2/FiO2nadir), all correlating with skewed T cell responses (higher perforin production by cytotoxic T cells as well as fewer and less polyfunctional SARS-CoV-2-specific T cells), despite preserved humoral immunity. In conclusion, these data suggest a link between HIV-related T cell dysfunction and poor control over SARS-CoV-2 replication/dissemination that may in turn influence COVID-19 severity in PLWH.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:27 |
---|---|
Enthalten in: |
iScience - 27(2024), 1 vom: 19. Jan., Seite 108673 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Augello, Matteo [VerfasserIn] |
---|
Links: |
---|
Themen: |
Biological sciences |
---|
Anmerkungen: |
Date Revised 09.01.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1016/j.isci.2023.108673 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM366791443 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM366791443 | ||
003 | DE-627 | ||
005 | 20240114233158.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240114s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.isci.2023.108673 |2 doi | |
028 | 5 | 2 | |a pubmed24n1253.xml |
035 | |a (DE-627)NLM366791443 | ||
035 | |a (NLM)38188525 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Augello, Matteo |e verfasserin |4 aut | |
245 | 1 | 0 | |a Association between SARS-CoV-2 RNAemia, skewed T cell responses, inflammation, and severity in hospitalized COVID-19 people living with HIV |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 09.01.2024 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © 2023 The Authors. | ||
520 | |a Severe COVID-19 outcomes have been reported in people living with HIV (PLWH), yet the underlying pathogenetic factors are largely unknown. We therefore aimed to assess SARS-CoV-2 RNAemia and plasma cytokines in PLWH hospitalized for COVID-19 pneumonia, exploring associations with magnitude and functionality of SARS-CoV-2-specific immune responses. Eighteen unvaccinated PLWH (16/18 on cART; median CD4 T cell count 361.5/μL; HIV-RNA<50 cp/mL in 15/18) and 18 age/sex-matched people without HIV were consecutively recruited at a median time of 10 days from symptoms onset. PLWH showed greater SARS-CoV-2 RNAemia, a distinct plasma cytokine profile, and worse respiratory function (lower PaO2/FiO2nadir), all correlating with skewed T cell responses (higher perforin production by cytotoxic T cells as well as fewer and less polyfunctional SARS-CoV-2-specific T cells), despite preserved humoral immunity. In conclusion, these data suggest a link between HIV-related T cell dysfunction and poor control over SARS-CoV-2 replication/dissemination that may in turn influence COVID-19 severity in PLWH | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Immunology | |
650 | 4 | |a Microbiology | |
650 | 4 | |a Virology | |
650 | 4 | |a biological sciences | |
650 | 4 | |a immune response | |
700 | 1 | |a Bono, Valeria |e verfasserin |4 aut | |
700 | 1 | |a Rovito, Roberta |e verfasserin |4 aut | |
700 | 1 | |a Tincati, Camilla |e verfasserin |4 aut | |
700 | 1 | |a Bianchi, Silvia |e verfasserin |4 aut | |
700 | 1 | |a Taramasso, Lucia |e verfasserin |4 aut | |
700 | 1 | |a Di Biagio, Antonio |e verfasserin |4 aut | |
700 | 1 | |a Callegaro, Annapaola |e verfasserin |4 aut | |
700 | 1 | |a Maggiolo, Franco |e verfasserin |4 aut | |
700 | 1 | |a Borghi, Elisa |e verfasserin |4 aut | |
700 | 1 | |a Monforte, Antonella d'Arminio |e verfasserin |4 aut | |
700 | 1 | |a Marchetti, Giulia |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t iScience |d 2018 |g 27(2024), 1 vom: 19. Jan., Seite 108673 |w (DE-627)NLM285332627 |x 2589-0042 |7 nnns |
773 | 1 | 8 | |g volume:27 |g year:2024 |g number:1 |g day:19 |g month:01 |g pages:108673 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.isci.2023.108673 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 27 |j 2024 |e 1 |b 19 |c 01 |h 108673 |